Skip to content

Celcuity CELC Other accrued liabilities

Other accrued liabilities at other companies

Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$847K-49.6%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$13.11M
Eli Lilly logo
Eli LillyLLY
Gilead Sciences logo
Gilead SciencesGILD
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Tenet Healthcare logo
Tenet HealthcareTHC

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's other accrued liabilities?
Celcuity (CELC) reported other accrued liabilities of $13.97M in Q1 2026.
What does other accrued liabilities mean?
This captures miscellaneous short-term obligations that do not fit into standard categories like accounts payable or accrued compensation. It often includes items such as customer deposits, short-term tax provisions, or other minor contractual liabilities. It provides insight into the breadth of the company's short-term financial commitments.